3.8 Review

Summary and comparison of recently updated post-polypectomy surveillance guidelines

Journal

INTESTINAL RESEARCH
Volume 21, Issue 4, Pages 443-451

Publisher

KOREAN ASSOC STUDY INTESTINAL DISEASES
DOI: 10.5217/ir.2023.00107

Keywords

Polypectomy; Surveillance; Guidelines; Colonoscopy; Colorectal polyp

Ask authors/readers for more resources

Recently, updated guidelines for post-polypectomy surveillance have been published by multiple societies, and this review summarizes and compares the recommendations of these guidelines. There are differences in the recommended surveillance intervals, particularly for different types of adenomas. Surveillance recommendations for patients with serrated polyps are limited, and more research is needed in this area.
Recently, updated guidelines for post-polypectomy surveillance have been published by the U.S. Multi-Society Task Force (USMSTF), the British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England (BSG/ACPGBI/PHE), the European Society of Gastrointestinal Endoscopy (ESGE), the Japan Gastroenterological Endoscopy Society (JGES), and the Korean Multi-Society Taskforce Committee. This review summarizes and compares the updated recommendations of these 5 guidelines. There are some differences between the guidelines for the recommended post-polypectomy surveillance intervals. In particular, there are prominent differences between the guidelines for 1-4 tubular adenomas < 10 mm with low-grade dysplasia (nonadvanced adenomas [NAAs]) and tubulovillous or villous adenomas. The USMSTF, JGES, and Korean guidelines recommend colonoscopic surveillance for patients with 1-4 NAAs and those with tubulovillous or villous adenomas, whereas the BSG/ACPGBI/PHE and ESGE guidelines do not recommend endoscopic surveillance for such patients. Surveillance recommendations for patients with serrated polyps (SPs) are limited. Although the USMSTF guidelines provide specific recommendations for patients who have undergone SPs removal, these are weak and based on very low quality evidence. Future studies should examine this topic to better guide the surveillance recommendations for patients with SPs. For countries that do not have separate guidelines, we hope that this review article will help select the most appropriate guidelines as per each country's healthcare environment. (Intest Res 2023;21:443-451 )

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available